Quick Answer
NANOVIRICIDES, INC. reported Cash And Cash Equivalents At Carrying Value of $1.56 million for the year ending 2025.
- NANOVIRICIDES, INC. showed a decrease of -67.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2005: $0.00 | Q2 2010: $6.96 million | Q3 2010: $7.68 million | Q4 2010: $7.68 million | Q1 2011: $7.76 million | Q2 2011: $9.22 million | Q3 2011: $10.88 million | Q4 2011: $12.10 million | Q1 2012: $12.98 million | Q3 2012: $12.93 million | Q4 2012: $13.88 million | Q1 2013: $15.46 million | Q3 2013: $19.20 million | Q4 2013: $16.95 million | Q1 2014: $33.27 million | Q3 2014: $41.12 million | Q4 2014: $35.26 million | Q1 2015: $33.92 million | Q3 2015: $29.48 million | Q4 2015: $28.24 million | Q1 2016: $25.60 million | Q3 2016: $21.91 million | Q4 2016: $19.30 million | Q1 2017: $16.16 million | Q2 2017: $15.10 million | Q3 2017: $13.51 million | Q4 2017: $12.05 million | Q1 2018: $10.62 million | Q3 2018: $6.08 million | Q4 2018: $3.90 million | Q1 2019: $4.24 million | Q3 2019: $875.0 thousand | Q4 2019: $707.6 thousand | Q1 2020: $6.11 million | Q3 2020: $21.79 million | Q4 2020: $18.39 million | Q1 2021: $22.90 million | Q3 2021: $19.70 million | Q4 2021: $17.34 million | Q1 2022: $15.57 million | Q3 2022: $12.92 million | Q4 2022: $11.45 million | Q1 2023: $9.65 million | Q3 2023: $6.97 million | Q4 2023: $5.25 million | Q1 2024: $3.26 million | Q3 2024: $3.87 million | Q4 2024: $3.96 million | Q1 2025: $2.54 million | Q2 2025: $1.56 million | Q3 2025: $1.13 million | Q4 2025: $5.15 million.
- Over the full 14 years of available data (2012 to 2025), NANOVIRICIDES, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 89.1%.
- Historical annual values: Fiscal year 2025: $1.56 million | Fiscal year 2024: $4.80 million | Fiscal year 2023: $8.15 million | Fiscal year 2022: $14.07 million | Fiscal year 2021: $20.52 million | Fiscal year 2020: $13.71 million | Fiscal year 2019: $2.56 million | Fiscal year 2018: $7.08 million | Fiscal year 2017: $15.10 million | Fiscal year 2016: $24.16 million | Fiscal year 2015: $31.47 million | Fiscal year 2014: $36.70 million | Fiscal year 2013: $13.92 million | Fiscal year 2012: $14.27 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: